Fresenius Kabi takes on Sagent Pharmaceuticals in patent battle

06-01-2017

Fresenius Kabi takes on Sagent Pharmaceuticals in patent battle

sfam_photo / Shutterstock.com

Healthcare company Fresenius Kabi has targeted Sagent Pharmaceuticals in a patent infringement lawsuit centring on generic versions of Naropin.


Fresenius Kabi, patent, patent infringement, ANDA, Sagent Pharmaceuticals, generics,

LSIPR